These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25264075)

  • 1. Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.
    Wen W; Wu W; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5102-6. PubMed ID: 25264075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.
    Wen W; Wu W; Romaine IM; Kaufmann K; Du Y; Sulikowski GA; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4562-6. PubMed ID: 23838260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.
    Ramos-Hunter SJ; Engers DW; Kaufmann K; Du Y; Lindsley CW; Weaver CD; Sulikowski GA
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5195-8. PubMed ID: 23916258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels.
    Kozek KA; Du Y; Sharma S; Prael FJ; Spitznagel BD; Kharade SV; Denton JS; Hopkins CR; Weaver CD
    ACS Chem Neurosci; 2019 Jan; 10(1):358-370. PubMed ID: 30136838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
    Sharma S; Kozek KA; Abney KK; Kumar S; Gautam N; Alnouti Y; David Weaver C; Hopkins CR
    Bioorg Med Chem Lett; 2019 Mar; 29(6):791-796. PubMed ID: 30718161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.
    Wieting JM; Vadukoot AK; Sharma S; Abney KK; Bridges TM; Daniels JS; Morrison RD; Wickman K; Weaver CD; Hopkins CR
    ACS Chem Neurosci; 2017 Sep; 8(9):1873-1879. PubMed ID: 28697302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297.
    Huang Y; Zhang Y; Kong S; Zang K; Jiang S; Wan L; Chen L; Wang G; Jiang M; Wang X; Hu J; Wang Y
    Biomed Pharmacother; 2018 May; 101():362-370. PubMed ID: 29499411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.
    Xu Y; Cantwell L; Molosh AI; Plant LD; Gazgalis D; Fitz SD; Dustrude ET; Yang Y; Kawano T; Garai S; Noujaim SF; Shekhar A; Logothetis DE; Thakur GA
    J Biol Chem; 2020 Mar; 295(11):3614-3634. PubMed ID: 31953327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of selective G protein-gated inwardly rectifying K+ channel agonist ML297 in the rat spinal cord.
    Kimura M; Shiokawa H; Karashima Y; Sumie M; Hoka S; Yamaura K
    PLoS One; 2020; 15(9):e0239094. PubMed ID: 32915912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.
    Wydeven N; Marron Fernandez de Velasco E; Du Y; Benneyworth MA; Hearing MC; Fischer RA; Thomas MJ; Weaver CD; Wickman K
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10755-60. PubMed ID: 25002517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.
    Kaufmann K; Romaine I; Days E; Pascual C; Malik A; Yang L; Zou B; Du Y; Sliwoski G; Morrison RD; Denton J; Niswender CM; Daniels JS; Sulikowski GA; Xie XS; Lindsley CW; Weaver CD
    ACS Chem Neurosci; 2013 Sep; 4(9):1278-86. PubMed ID: 23730969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel small-molecule selective activator of homomeric GIRK4 channels.
    Cui M; Xu K; Gada KD; Shalomov B; Ban M; Eptaminitaki GC; Kawano T; Plant LD; Dascal N; Logothetis DE
    J Biol Chem; 2022 Jun; 298(6):102009. PubMed ID: 35525275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, synthesis and biological characterization of a series of
    Sharma S; Lesiak L; Aretz CD; Du Y; Kumar S; Gautam N; Alnouti Y; Dhuria NV; Chhonker YS; Weaver CD; Hopkins CR
    RSC Med Chem; 2021 Aug; 12(8):1366-1373. PubMed ID: 34458739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor.
    Kunitomo J; Yoshikawa M; Fushimi M; Kawada A; Quinn JF; Oki H; Kokubo H; Kondo M; Nakashima K; Kamiguchi N; Suzuki K; Kimura H; Taniguchi T
    J Med Chem; 2014 Nov; 57(22):9627-43. PubMed ID: 25384088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells.
    Dhar MS; Plummer HK
    BMC Physiol; 2006 Aug; 6():8. PubMed ID: 16945134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
    Plummer HK; Dhar MS; Cekanova M; Schuller HM
    BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Molecular Switch Probe to Activate or Inhibit GIRK1 Heteromers In Silico Reveals a Novel Gating Mechanism.
    Gazgalis D; Cantwell L; Xu Y; Thakur GA; Cui M; Guarnieri F; Logothetis DE
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 2000 Apr; 129(8):1716-22. PubMed ID: 10780978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A real-time screening assay for GIRK1/4 channel blockers.
    Walsh KB
    J Biomol Screen; 2010 Dec; 15(10):1229-37. PubMed ID: 20938046
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.